Work

PD-1 blockade in combination with epigenetic therapy to antagonize tumor mesenchymal program and drive therapeutic efficacy in an esophageal adenocarcinoma model.

Year: 2025

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e16159

Authors: Hyun Young Park, Michael J. Topper, Ashten N Omstead, Erin Grayhack, Christopher Sherry, Arul Goel, Muhammad Anees, Alisha Faisal Khan, Ping Zheng, Patrick L Wagner, Benny Weksler, David L. Bartlett, Ronan Joseph Kelly, Vincent K. Lam, Stephen Baylin, Ali Hussainy Zaidi

Institutions: Allegheny Health Network, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Baylor University Medical Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410815773

FWCI:

Cites:

Cited by:

Related to: 10